From Name:
From Email:
To Name:
To Email:

Optional Message:

FDA approves Lucentis for diabetic eye disorder

from The Wall Street Journal

The U.S. Food and Drug Administration recently recommended wider approval of Roche Holding AG's eye drug, Lucentis. The agency approved the product to treat a condition called diabetic macular edema, which is related to diabetes, and is the leading cause of blindness among working-age Americans. more

Powered by MultiBriefs
7701 Las Colinas Blvd., Ste. 800, Irving, TX 75063